StrategicPartnershipsCSABMembers?AbbvieNeuroscience& Neurology$12.3MillionNIDAGrantReviewed >4,000OpportunitiesARCHVenturePartnersScientists&TechnologyDevelopersTop-tierInvestorsTheRockefellerUniversity2014 Top-quartileRankedVentureCapitalSanDiegoOffice$3.375BillionExitGatesFoundation1.02DPILeroyHood,M.D.,Ph.D.LydianNeurosciencesScientificExpertiseSundarKodiyalamSubstantialExitHistoryDivestitures$1 BillionGenentechCollaborationInfectiousDisease,Oncology,MicrobiomeTheRockefellerUniversityhigh-quality,cutting edgelife sciencecompaniesWuXiPharmaTechWeillCornellMedicineHarvardMedicalSchoolNon-DilutiveFundingExceptionalTrackRecordEntrepreneursTachiYamada,M.D.CorporateSpinoutsOncologyDiversityJanLundberg,Ph.D.LodoTherapeuticsCPRITPfizerVenturesMDAndersonCancerCenterEliLillyAdvisory&CorporateBoardsPronirasWRFCapitalWeillCornellMedicinePetraPharmaGatesFoundation150+Years’ExperienceSyndicationRodeoTherapeuticsAcademic&ResearchInstitutionsSyndicationPartnersSeattleOfficeTargetedTherapeutic(Asset)FinancingTemasekFund Inet IRRof 58.4%OperatingPartners?MagnoliaNeurosciencesGeneYeo,Ph.D.Turn-KeyFacilitiesLewisCantleyRodeoTherapeuticsUniversityofMinnesotaSingaporeOfficeBruceL.A.Carter,Ph.D.UniformedServicesUniversity2.85DVPIUTSouthwesternMedicalCenterCaseWesternReserveEmployeesSteveGillis,Ph.D.(BARDA)– onupdatedslide deckColumbiaUniversityDanaFarberCancerCapital-efficiencyAlexandriaVentureInvestmentsAI &MachineLearningApogenBiotechnologiesUTSouthwestern58.43%IRRNewYorkOfficeLodoTherapeuticsPennStateStrategicPartnershipsCSABMembers?AbbvieNeuroscience& Neurology$12.3MillionNIDAGrantReviewed >4,000OpportunitiesARCHVenturePartnersScientists&TechnologyDevelopersTop-tierInvestorsTheRockefellerUniversity2014 Top-quartileRankedVentureCapitalSanDiegoOffice$3.375BillionExitGatesFoundation1.02DPILeroyHood,M.D.,Ph.D.LydianNeurosciencesScientificExpertiseSundarKodiyalamSubstantialExitHistoryDivestitures$1 BillionGenentechCollaborationInfectiousDisease,Oncology,MicrobiomeTheRockefellerUniversityhigh-quality,cutting edgelife sciencecompaniesWuXiPharmaTechWeillCornellMedicineHarvardMedicalSchoolNon-DilutiveFundingExceptionalTrackRecordEntrepreneursTachiYamada,M.D.CorporateSpinoutsOncologyDiversityJanLundberg,Ph.D.LodoTherapeuticsCPRITPfizerVenturesMDAndersonCancerCenterEliLillyAdvisory&CorporateBoardsPronirasWRFCapitalWeillCornellMedicinePetraPharmaGatesFoundation150+Years’ExperienceSyndicationRodeoTherapeuticsAcademic&ResearchInstitutionsSyndicationPartnersSeattleOfficeTargetedTherapeutic(Asset)FinancingTemasekFund Inet IRRof 58.4%OperatingPartners?MagnoliaNeurosciencesGeneYeo,Ph.D.Turn-KeyFacilitiesLewisCantleyRodeoTherapeuticsUniversityofMinnesotaSingaporeOfficeBruceL.A.Carter,Ph.D.UniformedServicesUniversity2.85DVPIUTSouthwesternMedicalCenterCaseWesternReserveEmployeesSteveGillis,Ph.D.(BARDA)– onupdatedslide deckColumbiaUniversityDanaFarberCancerCapital-efficiencyAlexandriaVentureInvestmentsAI &MachineLearningApogenBiotechnologiesUTSouthwestern58.43%IRRNewYorkOfficeLodoTherapeuticsPennState

Home for the Holidays (& everyday) - Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
  1. Strategic Partnerships
  2. CSAB Members?
  3. Abbvie
  4. Neuroscience & Neurology
  5. $12.3 Million NIDA Grant
  6. Reviewed > 4,000 Opportunities
  7. ARCH Venture Partners
  8. Scientists & Technology Developers
  9. Top-tier Investors
  10. The Rockefeller University
  11. 2014 Top-quartile Ranked
  12. Venture Capital
  13. San Diego Office
  14. $3.375 Billion Exit
  15. Gates Foundation
  16. 1.02 DPI
  17. Leroy Hood, M.D., Ph.D.
  18. Lydian Neurosciences
  19. Scientific Expertise
  20. Sundar Kodiyalam
  21. Substantial Exit History
  22. Divestitures
  23. $1 Billion Genentech Collaboration
  24. Infectious Disease, Oncology, Microbiome
  25. The Rockefeller University
  26. high-quality, cutting edge life science companies
  27. WuXi PharmaTech
  28. Weill Cornell Medicine
  29. Harvard Medical School
  30. Non-Dilutive Funding
  31. Exceptional Track Record
  32. Entrepreneurs
  33. Tachi Yamada, M.D.
  34. Corporate Spinouts
  35. Oncology
  36. Diversity
  37. Jan Lundberg, Ph.D.
  38. Lodo Therapeutics
  39. CPRIT
  40. Pfizer Ventures
  41. MD Anderson Cancer Center
  42. Eli Lilly
  43. Advisory & Corporate Boards
  44. Proniras
  45. WRF Capital
  46. Weill Cornell Medicine
  47. Petra Pharma
  48. Gates Foundation
  49. 150+ Years’ Experience
  50. Syndication
  51. Rodeo Therapeutics
  52. Academic & Research Institutions
  53. Syndication Partners
  54. Seattle Office
  55. Targeted Therapeutic (Asset) Financing
  56. Temasek
  57. Fund I net IRR of 58.4%
  58. Operating Partners?
  59. Magnolia Neurosciences
  60. Gene Yeo, Ph.D.
  61. Turn-Key Facilities
  62. Lewis Cantley
  63. Rodeo Therapeutics
  64. University of Minnesota
  65. Singapore Office
  66. Bruce L.A. Carter, Ph.D.
  67. Uniformed Services University
  68. 2.85 DVPI
  69. UT Southwestern Medical Center
  70. Case Western Reserve
  71. Employees
  72. Steve Gillis, Ph.D.
  73. (BARDA) – on updated slide deck
  74. Columbia University
  75. Dana Farber Cancer
  76. Capital-efficiency
  77. Alexandria Venture Investments
  78. AI & Machine Learning
  79. Apogen Biotechnologies
  80. UT Southwestern
  81. 58.43% IRR
  82. New York Office
  83. Lodo Therapeutics
  84. Penn State